http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1336851-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_151000070f06f2a592b4d32b0a31b913 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96486 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2001-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31f53cb518cfa597f4d1f072f791924f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6543cb0e76e538f03595c84f2e651754 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da8d91da68aa9243013e01a4d9126627 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_392d1e6fcc73429f725ccbe2fa7c983f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f30e822770d3f80e3f9cd57737e448a0 |
| publicationDate | 2003-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1336851-A1 |
| titleOfInvention | Immunoassay method for membrane-bound matrix metalloprotease |
| abstract | It is made possible to quantify MT1-MMP and tonmeasure the enzymatic activity of MT1-MMP sensitively,naccurately and quickly with simple operations and reagents.nThe MT1-MMP quantifications and the MT1-MMP enzymatic activitynmeasurements can be carried out using quantitative immunoassaysnfor MT1-MMP with anti-MT1-MMP Ab and reagents used therefor,nfurther immunologically quantifying methods for a membernselected from (i) MT1-MMP released and/or solubilized from cellnmembrane with a surfactant and/or a reducing agent and (ii)nspontaneously solubilized MT1-MMP, reagents used therefor,nsolid-phased MT1-MMP, etc., thereby enabling the screening forna compound which promotes or inhibits the expression of MT1-MMPnor a compound which promotes or inhibits the enzymatic activitynof MT1-MMP, and facilitating the development and research fornvaluable pharmaceutical drugs. There are also provided anuseful testing drug for cancer or cancer metastasis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023012798-A3 |
| priorityDate | 2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1041.